Relapsed Refractory Ovarian Carcinoma clinical trials

Explore recruiting relapsed refractory ovarian carcinoma clinical trials.

Recruiting relapsed refractory ovarian carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Relapsed Refractory Ovarian Carcinoma trials by city

Relapsed Refractory Ovarian Carcinoma in Toronto Relapsed Refractory Ovarian Carcinoma in Vancouver Relapsed Refractory Ovarian Carcinoma in Montreal Relapsed Refractory Ovarian Carcinoma in Calgary Relapsed Refractory Ovarian Carcinoma in Edmonton Relapsed Refractory Ovarian Carcinoma in Ottawa Relapsed Refractory Ovarian Carcinoma in Winnipeg Relapsed Refractory Ovarian Carcinoma in Quebec City Relapsed Refractory Ovarian Carcinoma in Hamilton Relapsed Refractory Ovarian Carcinoma in Kitchener Relapsed Refractory Ovarian Carcinoma in London Relapsed Refractory Ovarian Carcinoma in Halifax Relapsed Refractory Ovarian Carcinoma in New York Relapsed Refractory Ovarian Carcinoma in Los Angeles Relapsed Refractory Ovarian Carcinoma in Chicago Relapsed Refractory Ovarian Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease